[Double urologic tumors: reduced immunocompetence?].
55 patients with primary multiple neoplasias underwent immunostaging with determination of the immunoglobulins, B- and T-lymphocyte counting, H3-lymphocyte stimulation (ConA, PWM, PHA) and DNCB-epidermal test. There were no significant differences between the PMN-group and a group of patients with solitary tumors, whereas both cancer patient groups revealed a diminished immunocompetence compared with a non-malignant control group of patients.
D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology; D004137:Dinitrochlorobenzene; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007121:Immunocompetence; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000276:immunology*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D014571:Urologic Neoplasms / Q000276:immunology*
D004137:Dinitrochlorobenzene; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M
Urologische Doppeltumoren: verminderte immunkompetenz?